GB1158283A - Composition to be Applied to Skin and Process for Preparing Same. - Google Patents

Composition to be Applied to Skin and Process for Preparing Same.

Info

Publication number
GB1158283A
GB1158283A GB4455866D GB4455866D GB1158283A GB 1158283 A GB1158283 A GB 1158283A GB 4455866 D GB4455866 D GB 4455866D GB 4455866 D GB4455866 D GB 4455866D GB 1158283 A GB1158283 A GB 1158283A
Authority
GB
United Kingdom
Prior art keywords
agent
acid
derivatives
pharmaceutically acceptable
coal tar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4455866D
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Foster Milburn Co
Original Assignee
Foster Milburn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Foster Milburn Co filed Critical Foster Milburn Co
Publication of GB1158283A publication Critical patent/GB1158283A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1,158,283. Compositions for topical application. FOSTER-MILBURN CO. 5 Oct., 1966 [21 Oct., 1965], No. 44558/66. Heading A5B. Compositions to be applied to the skin and having increased percutaneous absorption through and retention in skin comprise a stable, topically active chemical compound (e.g. an anti-acne agent, an anti-inflammatory agent, an anticholinergic, an emollient, a sex hormone, crude coal tar, an antipsoriatic agent or an antimetabolite) solubilized in a pharmaceutically acceptable vehicle having as one component an amide having the structural formula wherein R<SP>1</SP> is H or Me, R<SP>2</SP> is H or an alkyl radical containing not more than 2 carbon atoms, and R<SP>3</SP> is an alkyl radical containing not more than 2 carbon atoms. The amide is preferably N,N-dimethyl acetamide, N,N- dimethyl formamide or N,N-diethyl acetamide. The topically active chemical compound may be an anti-inflammatory agent, e.g. triamcinolone acetonide, fluocinolone acetonide, betamethasone valerate, flurandren alone acetonide and hydrocortisone, an anticholinergic e.g. hexopyrronium bromide, an antimetabolite e.g. 5-fluorouracil, 4-amino-n<SP>10</SP>-methylpteroylglutamic acid and b-mercaptopurine; an antimicrobial agent e.g. erythromycin, tetracyclines, chloromycetin, oleandomycin, chloramphenicol, 2,2'-methylenebis (3,4,6-trichlorophenol), 3,4',5-tribromosalicylanilide, 3,4,4'- trichlorocarbanilide, nystatin, undecylenic acid, sulphur, salicylic acid, parachlorometaxylenol, 2-(4'-thiazolyl)-benzimidazole, iodine, iodochlorhydroxyguin- and 5-iodo-2'-deoxyuridine, an emollient e.g. lanolin and lanolin alcohols and their ethoxylated and/or acetylated products, glycerol, glycols and their derivatives, fatty acids, their esters, alcohols and derivatives; a sex hormone e.g. testosterone and oestradial; a sunscreen agent e.g. para-aminobenzoic acid, amyl p-dimethylaminobenzoate, cinnamic acid and benzophenones and their derivatives and coal tar products including anthracene and a composition containing sulphur, salicylic acid, hexachlorophene and crude coal tar extract. The amides may be used alone or in combination with other additional pharmaceutically acceptable surface active agents, emulsifiers, solvents, vehicles or other pharmaceutically acceptable bases.
GB4455866D 1965-10-21 1966-10-05 Composition to be Applied to Skin and Process for Preparing Same. Expired GB1158283A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49933065A 1965-10-21 1965-10-21

Publications (1)

Publication Number Publication Date
GB1158283A true GB1158283A (en) 1969-07-16

Family

ID=23984853

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4455866D Expired GB1158283A (en) 1965-10-21 1966-10-05 Composition to be Applied to Skin and Process for Preparing Same.

Country Status (1)

Country Link
GB (1) GB1158283A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2133690A (en) * 1983-01-10 1984-08-01 Young & Company Limited Robert Percutaneous levamisole compositions
FR2547503A1 (en) * 1983-05-20 1984-12-21 Nitto Electric Ind Co NOVEL SOLVENT-AUXILIARY PENETRATION SYSTEM FOR THE ADMINISTRATION OF PHYSIOLOGICALLY ACTIVE AGENTS BY PERCUTANEOUS ADMINISTRATION
WO2008104532A1 (en) * 2007-02-26 2008-09-04 Galderma Research & Development Topical composition comprising fluocinolone acetonide for use in depigmentation of the skin
US8466138B2 (en) 2005-10-12 2013-06-18 Unimed Pharmaceuticals, Llc Testosterone gel and method of use
US9125816B2 (en) 2000-08-30 2015-09-08 Besins Healthcare Inc. Pharmaceutical composition and method for treating hypogonadism

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2133690A (en) * 1983-01-10 1984-08-01 Young & Company Limited Robert Percutaneous levamisole compositions
FR2547503A1 (en) * 1983-05-20 1984-12-21 Nitto Electric Ind Co NOVEL SOLVENT-AUXILIARY PENETRATION SYSTEM FOR THE ADMINISTRATION OF PHYSIOLOGICALLY ACTIVE AGENTS BY PERCUTANEOUS ADMINISTRATION
US9132089B2 (en) 2000-08-30 2015-09-15 Besins Healthcare Inc. Pharmaceutical composition and method for treating hypogonadism
US9125816B2 (en) 2000-08-30 2015-09-08 Besins Healthcare Inc. Pharmaceutical composition and method for treating hypogonadism
US8486925B2 (en) 2005-10-12 2013-07-16 Unimed Pharmaceuticals, Llc Testosterone gel and method of use
US8466137B2 (en) 2005-10-12 2013-06-18 Unimed Pharmaceuticals, Llc Testosterone gel and method of use
US8466136B2 (en) 2005-10-12 2013-06-18 Unimed Pharmaceuticals, Llc Testosterone gel and method of use
US8729057B2 (en) 2005-10-12 2014-05-20 Unimed Pharmaeuticals, LLC Testosterone gel and method of use
US8741881B2 (en) 2005-10-12 2014-06-03 Unimed Pharmaceuticals, Llc Testosterone gel and method of use
US8754070B2 (en) 2005-10-12 2014-06-17 Unimed Pharmaceuticals, Llc Testosterone gel and method of use
US8759329B2 (en) 2005-10-12 2014-06-24 Unimed Pharmaceuticals, Llc Testosterone gel and method of use
US8466138B2 (en) 2005-10-12 2013-06-18 Unimed Pharmaceuticals, Llc Testosterone gel and method of use
WO2008104532A1 (en) * 2007-02-26 2008-09-04 Galderma Research & Development Topical composition comprising fluocinolone acetonide for use in depigmentation of the skin

Similar Documents

Publication Publication Date Title
US4323558A (en) Topical trien containing pharmaceutical compositions and methods of use
US4557934A (en) Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
US4954487A (en) Penetrating topical pharmaceutical compositions
KR930007444A (en) Pharmaceutical composition containing 4-biphenylacetic acid (BPAA)
US4130643A (en) Dermatological compositions
US3952099A (en) Dermatological compositions
US3592930A (en) Moisture-deterioratable topical medicaments,particularly anti-inflammatory steroids,in a substantially non-aqueous fatty alcohol-propylene glycol vehicle
US10953021B2 (en) Topical compositions of flunisolide and methods of treatment
DE3783683T2 (en) SKIN PENETRATION-IMPROVING COMPOSITIONS.
US4150114A (en) Dermatological compositions
US3749773A (en) Gelled steroid ointment
KR100952786B1 (en) Pharmaceutical composition
NZ197668A (en) Composition for topical use containing a diol and a cell envelope-disordering compound
GB1593786A (en) Pharmaceutical formulations
IE43655B1 (en) Pharmaceutical composition
US4048310A (en) Topical steroid formulation in form of lotion or cream
CA1139665A (en) Corticosteroid formulations containing sebacate carrier
GB1158283A (en) Composition to be Applied to Skin and Process for Preparing Same.
GB1349955A (en) Dermatological composition
US3856954A (en) Topical steroid compositions
US4473565A (en) Topical anti-inflammatory drug therapy
IE41287L (en) Steroid pharmaceutical composition
US3689667A (en) C22 acid and its salts to promote wound healing
ES479691A1 (en) Solid stable pharmaceutical composition on the basis of a 1,3-diester of 17-alpha-ethynyl-7-alpha-methyl-1,3,5(10)-estratriene-1,3,17-beta-triol.
IE39113B1 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]